Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding outcome of Board meeting held on January 06, 2026.
GKSL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts more than Nifty Microcap 250 and 3.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board of Gujarat Kidney and Super Speciality Limited met on January 6, 2026 and approved two key acquisitions in the healthcare space. First, the company will acquire the remaining 49% equity stake (4,90,000 shares) in Harmony Medicare Private Limited for Rs. 10.78 crore in cash, converting it into a wholly owned subsidiary. Harmony Medicare, based in Bharuch, Gujarat, reported a turnover of Rs. 42.29 crore in FY25 and is already a related party. Second, the board approved payment of the balance Rs. 12.40 crore (out of total Rs. 14 crore) for the 100% acquisition of Ashwini Medical Centre in Anand, Gujarat, to be funded from IPO proceeds. Ashwini Medical Centre, a medical and pharmacy service provider, had a turnover of Rs. 4.51 crore in FY25. Both acquisitions are expected to be completed in approximately two months.
These acquisitions strengthen the company's footprint in Gujarat's healthcare sector and consolidate its control over Harmony Medicare. Funding the Ashwini deal from IPO proceeds signals deployment of recently raised capital towards inorganic growth, which is positive for shareholders if integration delivers the expected synergies.